Synopsis
Synopsis
0
KDMF
0
FDA Orange Book
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Antiminth
2. Combantrin
3. Embonate, Pyrantel
4. Embovin
5. Pamoate, Pyrantel
6. Pyrantel Embonate
1. 22204-24-6
2. Pyrantel Embonate
3. Antiminth
4. Combantrin
5. Pyrantel (pamoate)
6. Cp-10,423-16
7. Pyrantel (as Pamoate)
8. Embovin
9. (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
10. Nsc-355080
11. Chebi:8655
12. Cp 10423-16
13. 81bk194z5m
14. Nsc355080
15. (e)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6-tetrahydropyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate)
16. Cp-10423-16
17. Cp-10423-18
18. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)-, (e)-, Compd. With 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic Acid) (1:1)
19. Cobantril
20. Sentry Hc Worm X
21. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis[3-hydroxy-, Compd. With 1,4,5,6-tetrahydro-1-methyl-2-[(1e)-2-(2-thienyl)ethenyl]pyrimidine (1:1)
22. 4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic Acid; 1-methyl-2-[(e)-2-(2-thienyl)vinyl]-5,6-dihydro-4h-pyrimidine
23. 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine
24. Sentry Hc Worm X Ds
25. Einecs 244-837-1
26. Vetscription Sure Shot 2x
27. Nsc 355080
28. Pyirantelpamoate
29. Unii-81bk194z5m
30. Pyrantel Pamoates
31. Pyranteli Embonas
32. Antiminth (tn)
33. Pyrantel Pamoate [usan:usp:jan]
34. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With 1,4,5,6-tetrahydro-1-methyl-2-((1e)-2-(2-thienyl)ethenyl)pyrimidine (1:1)
35. Spectrum5_001373
36. Pyrantel Pamoate, Bioxtra
37. (3-hydroxy-2-naphthoate)
38. Schembl41025
39. 2-naphthalenecarboxylic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)pyrimidine (1:1)
40. Pyrantel Pamoate [mi]
41. Spectrum1500517
42. Pyrantel Pamoate [jan]
43. Pyrantel Pamoate (jp17/usp)
44. Schembl7793068
45. Pyrantel Pamoate [usan]
46. Chembl1599768
47. Pyrantel Pamoate [vandf]
48. Hms500m16
49. Pyrantel Pamoate Sigmaultra,(s)
50. Amy3564
51. Dtxsid40897057
52. Pyrantel Embonate [mart.]
53. Pyrantel Pamoate [usp-rs]
54. Hms1920n06
55. Hms2090j21
56. Hms2092e07
57. Pharmakon1600-01500517
58. Pyrantel Embonate [who-dd]
59. Pyrantel Embonate [who-ip]
60. Ccg-39242
61. Mfcd00072037
62. Nsc757303
63. S2501
64. Stl481883
65. Pyrantel Pamoate [green Book]
66. Akos015908224
67. Cs-3869
68. Nsc-757303
69. Idi1_000254
70. Pyrantel Embonate [ep Monograph]
71. Pyrantel Pamoate [usp Monograph]
72. Ncgc00094552-01
73. Ncgc00094552-02
74. Ncgc00094552-03
75. Pyranteli Embonas [who-ip Latin]
76. 2-naphthoic Acid, 4,4'-methylenebis(3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1)
77. 4,4'-methylenebis(3-hydroxy-2-naphthoic) Acid, Compound With (e)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine (1:1)
78. Ac-24204
79. As-12185
80. Bp166202
81. Hy-12640
82. Sbi-0051499.p003
83. C07389
84. D00486
85. F21340
86. 204p246
87. A816013
88. Sr-05000001708
89. Q3489331
90. Sr-05000001708-1
91. Pyrantel Pamoate, Vetranal(tm), Analytical Standard
92. (e)-1-methyl-2-(2-(thiophen-2-yl)vinyl)-1,4,5,6
93. Pyrantel Embonate, European Pharmacopoeia (ep) Reference Standard
94. Pyrantel Pamoate, United States Pharmacopeia (usp) Reference Standard
95. Pyrimidine,1,4,5,6-tetrahydro-1-methyl-2-[(1e)-2-(2-thienyl)ethenyl]-
96. (e)-1,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine 4,4'-methylenebis[3-hydroxy-2-naphthoate] (1:1)
97. 2-naphthalenecarboxylic Acid,4'-methylenebis[3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)ethenyl]pyrimidine (1:1)
98. 2-naphthoic Acid,4'-methylenebis[3-hydroxy-, Compd. With (e)-1,4,5,6-tetrahydro-1-methyl-2-[2-(2-thienyl)vinyl]pyrimidine (1:1)
99. 4,4'-methanediylbis(3-hydroxynaphthalene-2-carboxylic Acid) - 1-methyl-2-[(e)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine (1:1)
100. 4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic Acid,1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine
101. Pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-[2-(-2-thienyl)ethenyl-, (e)-, With 4,4'-methylenebis[3-hydroxy-2-naphthalenecarboxylic Acid (1:1)
| Molecular Weight | 594.7 g/mol |
|---|---|
| Molecular Formula | C34H30N2O6S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 594.18245785 g/mol |
| Monoisotopic Mass | 594.18245785 g/mol |
| Topological Polar Surface Area | 159 Ų |
| Heavy Atom Count | 43 |
| Formal Charge | 0 |
| Complexity | 816 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
About the Company : Since 1962, MOEHS has produced high-quality Active Pharmaceutical Ingredients (APIs) for the global market. With decades of technical expertise, Moehs Group delivers pharmaceutical...
About the Company : Established in 1991, Pharm-Rx is an importer and distributor of active ingredients serving the pharmaceutical, nutritional supplement, and food industries. The company follows a hi...
Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.
About the Company : Cosma S.p.A., part of the CFM Group with AMSA and Clarochem Ireland, is the group’s largest manufacturing site in Bergamo, Italy. With 130,000L glass-lined reaction volume and ov...
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
About the Company : Willow Birch Pharma, Inc. is a premier supplier of bulk APIs to North American Compounding Pharmacies, sourcing from FDA registered and GMP manufacturers. With licenses in all 50 s...
About the Company : Daishang Chemical Co., Ltd. established in January 2005, sticking to the guiding principle "Technical innovation, Quality Orientation", we practice best of technology innovation, o...

About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pha...

About the Company : We commit to be a customer focused business and acknowledge that to be successful we have to make the opportunity offered by our clients work for them and for the future prosperity...

About the Company : With over 85 years of experience, Uquifa provides comprehensive services supporting projects from proof of concept to commercial manufacturing. Uquifa’s business model is built o...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Suspension, Tablet
Grade : Topical, Oral
Category : Coating Systems & Additives, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Thickeners and Stabilizers
Brand Name : Carboxymethyl Cellulose
Application : Coating Systems & Additives, Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Thickeners and Stabilizers
Excipient Details : Carboxymethylcellulose serves as a disintegrant, binder, coating agent & thickener in oral formulations, also as a stabilizer in topical formulations.
Dosage Form : Capsule, Cream / Lotion / Ointment, Emulsion, Gel, Injectable / Parenteral, Suspension, Tablet
Grade : Parenteral, Oral, Topical
Category : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Application : Emulsifying Agents, Film Formers & Plasticizers, Parenteral, Solubilizers, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : Polysorbate 80 is used as a plasticizer, solubilizer, emulsifier, surfactant, and suspension stabilizer. It is also used in parenteral products.
Dosage Form : Cream / Lotion / Ointment, Emulsion, Injectable / Parenteral, Softgels, Tablet
Grade : Oral, Topical, Parenteral
Category : Film Formers & Plasticizers, Parenteral, Topical

Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgels
Grade : Parenteral, Oral, Topical
Category : Film Formers & Plasticizers, Parenteral, Thickeners and Stabilizers, Topical
Application : Taste Masking
Pharmacopoeia Ref : Not Available
Technical Specs : Pharma Grade/Food Grade
Ingredient(s) : Sorbitol
Grade : Not Available
Category : Coating Systems & Additives, Film Formers & Plasticizers
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
70
PharmaCompass offers a list of Pyrantel Pamoate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Pyrantel Pamoate manufacturer or Pyrantel Pamoate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pyrantel Pamoate manufacturer or Pyrantel Pamoate supplier.
A Cobantril manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cobantril, including repackagers and relabelers. The FDA regulates Cobantril manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cobantril API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cobantril manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Cobantril supplier is an individual or a company that provides Cobantril active pharmaceutical ingredient (API) or Cobantril finished formulations upon request. The Cobantril suppliers may include Cobantril API manufacturers, exporters, distributors and traders.
click here to find a list of Cobantril suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Cobantril DMF (Drug Master File) is a document detailing the whole manufacturing process of Cobantril active pharmaceutical ingredient (API) in detail. Different forms of Cobantril DMFs exist exist since differing nations have different regulations, such as Cobantril USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cobantril DMF submitted to regulatory agencies in the US is known as a USDMF. Cobantril USDMF includes data on Cobantril's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cobantril USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cobantril suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cobantril Drug Master File in Japan (Cobantril JDMF) empowers Cobantril API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cobantril JDMF during the approval evaluation for pharmaceutical products. At the time of Cobantril JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cobantril suppliers with JDMF on PharmaCompass.
A Cobantril CEP of the European Pharmacopoeia monograph is often referred to as a Cobantril Certificate of Suitability (COS). The purpose of a Cobantril CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cobantril EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cobantril to their clients by showing that a Cobantril CEP has been issued for it. The manufacturer submits a Cobantril CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cobantril CEP holder for the record. Additionally, the data presented in the Cobantril CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cobantril DMF.
A Cobantril CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cobantril CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cobantril suppliers with CEP (COS) on PharmaCompass.
A Cobantril written confirmation (Cobantril WC) is an official document issued by a regulatory agency to a Cobantril manufacturer, verifying that the manufacturing facility of a Cobantril active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cobantril APIs or Cobantril finished pharmaceutical products to another nation, regulatory agencies frequently require a Cobantril WC (written confirmation) as part of the regulatory process.
click here to find a list of Cobantril suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cobantril as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cobantril API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cobantril as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cobantril and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cobantril NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cobantril suppliers with NDC on PharmaCompass.
Cobantril Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cobantril GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cobantril GMP manufacturer or Cobantril GMP API supplier for your needs.
A Cobantril CoA (Certificate of Analysis) is a formal document that attests to Cobantril's compliance with Cobantril specifications and serves as a tool for batch-level quality control.
Cobantril CoA mostly includes findings from lab analyses of a specific batch. For each Cobantril CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cobantril may be tested according to a variety of international standards, such as European Pharmacopoeia (Cobantril EP), Cobantril JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cobantril USP).